Skip to main content
Equibles
KRMD logo

KRMD · KORU Medical Systems, Inc. · Metrics

Track KRMD — free

Use KRMD with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research KRMD.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$3.18 +0.01 (+0.32%) Q2 2026 earnings call transcript
Russell 2000 member Rebalance outlook locked
Market Cap
$146.36M
Shares
46.17M
Volume · Oct 28 15.38K Avg daily vol (3M) 240.26K

KRMD metrics

97 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$3.17
Market cap
$146.36M

Price action

20 metrics
Price change (1W)
+4.3%
Price change (30D)
+3.6%
Price change (3M)
-20.9%
Price change (6M)
-22.3%
Price change (YTD)
-45.4%
Price change (1Y)
-23.2%
Trailing year
Price change (5Y)
+25.8%
52-week high
$6.52
52-week low
$2.93
Change from 52-week high
-51.4%
Change from 52-week low
+8.2%
Annualized volatility
48.5%
Annualized volatility (3M)
38.9%
Beta
0.6
RSI (14D)
55.2
Price vs SMA 50
+0.8%
Price vs SMA 200
-21.9%
Avg volume (3M)
240,258
Relative volume
0.5
Average dollar volume
$787,018

Company

3 metrics
Sector
Healthcare
Industry
Medical Instruments & Supplies
Shares outstanding
46.17M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
3.0×
reciprocal yield 33.2%
EV / EBITDA
—
EV / EBIT
—
P / sales
3.2×
reciprocal yield 31.3%
P / book
8.0
reciprocal yield 12.5%
FCF yield
0.5%
TTM · current market cap
Buyback yield
0.0%
P / FCF
185.5
reciprocal yield 0.5%
P / operating cash flow
103.6
reciprocal yield 1.0%
Earnings yield
-1.3%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
3.7×
reciprocal yield 26.9%
EV / revenue historical average (5Y)
4.2×
reciprocal yield 23.9%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
585.5×
reciprocal yield 0.2%
EV / EBITDA historical average (5Y)
585.5×
reciprocal yield 0.2%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
0.0%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
2026-11-10
Last earnings
2026-08-05

Profitability

9 metrics
Gross margin
62.4%
Operating margin
-3.7%
Trailing 12 months
Net margin
-4.0%
Gross profit (TTM)
$28.16M
Operating profit (TTM)
−$1.65M
Net income (TTM)
−$1.82M
Trailing 12 months
Diluted EPS (TTM)
$-0.04
FCF margin
1.7%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$0.96
Gross profit per diluted share (TTM)
$0.60
Operating profit per diluted share (TTM)
$-0.04
EBITDA per diluted share (TTM)
$-0.02
Net income per diluted share (TTM)
$-0.04
Operating cash flow per diluted share (TTM)
$0.03
Free cash flow per diluted share (TTM)
$0.02
Capital expenditures per diluted share (TTM)
$0.01
R&D per diluted share (TTM)
$0.09
Stock compensation per diluted share (TTM)
$0.06
Book value per share
$0.37

Growth

11 metrics
Revenue growth YoY
+18.2%
Year over year
Net income growth YoY
—
Revenue (TTM)
$45.11M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+7.2%
Year over year · more shares
Revenue CAGR (3Y)
+13.8%
Revenue CAGR (5Y)
+11.2%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-10.1%
Return on assets
-6.5%
Debt / equity
0.0
Current ratio
2.7
EBITDA (TTM)
−$861,496
Free cash flow (TTM)
$776,653
Quick ratio
2.1
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$8.07M
Latest balance sheet
Cash & equivalents
$8.29M
Total assets
$27.96M
Total debt
$220,001

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$1.39M
Capital expenditures (TTM)
$614,335
R&D (TTM)
$4.46M
SG&A (TTM)
$24.56M
Stock compensation (TTM)
$2.74M
R&D / revenue
9.9%
Stock compensation / revenue
6.1%

Ownership (13F)

9 metrics
13F filers
84
13F filer change QoQ
-8
Institutional ownership
44.5%
Conviction holders (share of 13F filers)
1.2%
Crowding (high-turnover and private-fund holders)
14.8%
Private-fund adviser ownership
13.9%
Active holders' share change QoQ
-9.4%
Holder tenure
12.8
Price vs estimated holder cost
+9.0%

Ownership (registered funds)

1 metrics
Index-fund ownership
11.3%

Short interest

3 metrics
Short interest
1.9%
Latest settlement · 4.0 days to cover
Days to cover
4.0d
Short-squeeze score
58 / 100

Insider activity

2 metrics
Net insider buying (90D)
$101,120
Insider-sentiment score
81 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 704440 CUSIP 759910102 13F (30d) 6 filings 6 filers Visit website Investor relations